Besides, Arch, DNAP has suddenly become a blip on a lot more radars among the investment community.
This bodes well for the NIJ grant we've applied for, plus as Chig mentioned, patent approval, and as important, timelines for patent protection.
Pretty difficult for another company to later begin using the science and prove against a lawsuit they had it first.